CAR-T Therapy Market Is Thriving Worldwide 2020 | Trends, Growth And Profit Analysis, Forecast To 2030

The Business Research Company’s CAR-T Therapy Market Report - Opportunities And Strategies - Global Forecast To 2030.

Avail up to 50% off on ALL research reports at: https://www.thebusinessresearchcompany.com/global-market-reports. Offer applies until Dec 31st.

The global CAR-T therapy market reached a value of nearly $734.0 million in 2019. The market is expected to grow from $734.0 million in 2019 to $ 2,250 million in 2023 at a rate of 32.3%. The growth is mainly due to an increased prevalence of cancer and increased awareness about the therapy. The market is expected to stabilize and reach $3,150 million in 2025 and $ 6,100 million in 2030.

The Key drivers of the CAR-T therapy market include:-
The rise in the number of blood cancer cases across the globe is likely to contribute to the growth of the CAR-T therapy market during the forecast period. Therefore, the rise in the blood cancer incidence rate globally is anticipated to boost the demand for the CAR-T therapy market over the forthcoming years.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

CAR-T Therapy Market Segmentation:-
By Target Antigen
1. CD19 Therapy
2. CD22 Therapy
3. BCMA Therapy
4. Others

The CD19 was the largest segment of the CAR-T therapy market by target antigen, accounting for 100% of the total market in 2019. Going forward, CD19 segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 25.3%.

By Application
1. Acute Lymphoblastic Leukemia
2. Diffuse Large B-Cell Lymphoma
3. Follicular Lymphoma
4. Chronic Lymphocytic Leukemia
5. Multiple Myeloma
6. Others

The diffuse large B-cell lymphoma was the largest segment of the CAR-T therapy market by application, accounting for 56.1% of the total market in 2019. Going forward, the others segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 29.3%.

Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2808&type=smp

By Geography - The CAR-T therapy market is segmented I nto
1.North America
2.Western Europe
3.Asia Pacific
4.Eastern Europe
5.South America
6.Middle East
7.Africa

Some of the major key players involved in the CAR-T therapy market are
1. Gracell Biotechnology Ltd
2. Aeon Therapeutics
3. CARsgen Therapeutics
4. Daiichi Sankyo
5. Celegne

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2808

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.